Determinants of access to anticancer medicines in South Asia: a multi method study - TizigPharma | Shaping the future of healthcare with innovative, high-quality, and cost-effective solutions.

Scientific Insights

Determinants of access to anticancer medicines in South Asia: a multi method study

medicines in South Asia: a multimethod study

May 18, 2026

medicines in South Asia: a

multimethod study

Access to anticancer medicines in South Asia Download

Tizig Pharma

Leave a Reply Cancel reply

Related Posts

Scientific Insights

Determinants of access to anticancer medicines in South Asia: a multi method study

May 18, 2026
Scientific Insights

Hydroxyurea and blood transfusion therapy for Sickle cell disease in South Asia: inconsistent treatment of a neglected disease

May 15, 2025
Scientific Insights

Osimertinib with or without Chemotherapy in EGFR-Mutated Advanced NSCLC

May 15, 2025

shaping the future of healthcare

Resources

Corporate Office

Maligaun-5, Kathmandu,

Phone No: 01-5912699

Email: [email protected]

Factory

Tukucha-1, Nala, Banepa, Kavre,

Phone No: 011-411241

Email: [email protected]

© Copyright 2024 Tizig Pharma Pvt. Ltd. All rights reserved.